Nephrologists Transforming Dialysis Safety

Targeting Zero Infections: MDROs and Antimicrobial Stewardship in the Dialysis Facility

Wednesday, September 27, 2017 12:00 PM - 1:00 PM

Thank you for your interest in Targeting Zero Infections: Multi-Drug Resistant Organisms (MDROs) and Antimicrobial Stewardship in the Dialysis Facility webinar that was held on September 27, 2017. The recorded webinar and slide deck will be available on the ASN Learning Center in November. Please check back for updates.

Wednesday, September 27, 2017 | 12:00 PM-1:00 PM EDT

Multidrug-resistant organisms (MDRO) are an important cause of healthcare associated infection and these infections are associated with significant morbidity and mortality. Patients undergoing dialysis are at higher risk of infection due to MDRO because of the communal dialysis setting and substantial antibiotic exposure. This educational session will review MDRO prevalence and spread in the outpatient dialysis facility and how to improve antimicrobial prescribing patterns with antimicrobial stewardship programs.

Webinar Highlights:

  • An MDRO case with a potentially diastrous outcome
  • Why your facility needs an antimicrobial stewardship program
  • Resources to help you and your team target zero infections

Upon completion of this session, the participant will be able to:

  • Describe the impact of MDROs in the dialysis population
  • Explain the mechanism of MDRO spread and ways to prevent it in the outpatient dialysis facility
  • List the elements of an effective Antimicrobial Stewardship Program (ASP)

Moderators

Alan S. Kliger, MD

Clinical Professor of Medicine, Yale University School of Medicine and
Vice President, Medical Director of Clinical Integration, Yale New Haven Health System
New Haven, CT

Susie Stark

NTDS Director
American Society of Nephrology
Washington, DC

Speakers

T. Alp Ikizler, MD, FASN

Co-Chair, NTDS Current & Emerging Threats Workgroup
Professor of Medicine
Director of Clinical Research in Nephrology
Director, Master of Science in Clinical Investigation Program
Vanderbilt University School of Medicine
Nashville, TN

Erika D'Agata, MD, MPH

Member, NTDS Current & Emerging Threats Workgroup
Professor of Medicine
Brown University
Providence, RI

Disclosures

All faculty, planner, and staff disclosures here.

Target Audience

  • Medical Directors
  • Nephrologists
  • Nurses
  • Technicians
  • Nephrology Fellows
  • Other

Accreditation and Continuing Education Credit Designation Statements

CME Credit

The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Nephrology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit
Joint Accreditation Provider

In support of improving patient care, this activity has been planned and implemented by the University of Minnesota, Interprofessional Continuing Education and the American Society of Nephrology. University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is awarded up to 1.0 ANCC contact hour.